The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (2, 4, 6 hours) prior to anesthesia induction and compare it to the control (current institutional standard of care where no Miralax is given on the day of surgery).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
200
Stopping Miralax ingestion 4 hours prior to anesthesia induction
Stopping Miralax ingestion 6 hours prior to anesthesia induction
Stopping Miralax ingestion 2 hours prior to anesthesia induction
Residual gastric volume as measured by EGD
Time frame: To be performed at the start of the EGD immediately after anesthesia induction.
Preoperative gastric POCUS volume assessment
Time frame: Performed prior to anesthesia induction
Effectiveness of colonoscopy cleanout
The effectiveness of colonoscopy cleanout will be assessed by the Boston Bowel Preparation Scale (BBPS).
Time frame: Performed during the colonoscopy portion following upper GI endoscopy (EGD)
Incidence of aspiration on induction and perioperative aspiration
Time frame: On anesthesia induction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Miralax will not be given on the day of surgery